Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Core IM | Internal Medicine Podcast

#53 Heparin-Induced Thrombocytopenia: 5 Pearls Segment

13 Nov 2019

Description

 Get CME Credit with ACP! Full Transcript with references and show notes Time Stamps4:30 What is the daily risk of thrombosis if HIT Is left untreated?5:40 What happens during platelet activation?07:11 How long does it take for patients to develop for IgG antibodies to Heparin to form?09:52 Is HIT common?10:28 Who is at higher risk for HIT?11:48 Why does low molecular weight heparin have a lower risk for HIT than unfractionated heparin?15:30 Approach to thrombocytopenia17:44 How do medications cause thrombocytopenia?18:38 With medications, what is the time course between medication initiation and thrombocytopenia?22:20 What is the sensitivity and specificity of anti-PF4 antibody?23:58 How does the serotonin-release assay (SRA) work?29:10 What type of anticoagulant do you choose for treating HIT?31:58 Why is it important to not use warfarin in patients with platelet counts <150,000?33:32 What is the treatment duration for a patient has confirmed HIT?36:29 Dr. Cuker’s story and the "Scarlet H"39:07 Dr. Linkin’s Recap42:25 Dr. Linkin’s story44:37 Pearl 5: Throwback to coronary calcium scores  Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840Our Sponsors:* Check out Branch Basics: https://branchbasics.com/COREIM and use the code CoreIM for 15% * Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com* Check out Washington Red Raspberries: https://redrazz.orgAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.